Zim Laboratories (ZIMLAB)
STALWARTScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹84.37 |
| Market Cap | ₹373.16 Cr |
| P/E Ratio | 53.38 |
| ROCE | 8.16% |
| ROE | 3.46% |
| Dividend Yield | 0% |
| Profit Growth | 10% |
| Debt/Equity | 0.49 |
| Sales Growth | 12.8% |
| Promoter Holding | 33.26% |
| 52-Week Range | ₹59.31 — ₹127 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹49.25 |
Zim Laboratories trades with a P/E ratio of 53.38, ROCE of 8.16%, ROE of 3.46%, profit growth of 10%, debt-to-equity of 0.49.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer